Literature DB >> 11997389

Conserved amino acids within CCAAT enhancer-binding proteins (C/EBP(alpha) and beta) regulate phosphoenolpyruvate carboxykinase (PEPCK) gene expression.

Luis A Jurado1, Shulan Song, William J Roesler, Edwards A Park.   

Abstract

Thyroid hormone and cAMP stimulate transcription of the gene for phosphoenolpyruvate carboxykinase (PEPCK). CCAAT enhancer-binding proteins (C/EBP(alpha) and beta) are involved in multiple aspects of the nutritional, developmental and hormonal regulation of PEPCK gene expression. Previously, we have identified a thyroid hormone response element in the PEPCK promoter and demonstrated that C/EBP proteins bound to the P3(I) site are participants in the induction of PEPCK gene expression by thyroid hormone and cAMP. Here, we identify several peptide regions within the transactivation domain of C/EBP(alpha) that enhance the ability of T(3) to stimulate gene transcription. We also demonstrate that several conserved amino acids in the transactivation domain of C/EBP(alpha) and C/EBPbeta are required for the stimulation of basal gene expression and identify amino acids within C/EBPbeta that participate in the cAMP induction of the PEPCK gene. Finally, we show that the CREB-binding protein (CBP) enhanced the induction of PEPCK gene transcription by thyroid hormone and that CBP is associated with the PEPCK gene in vivo. Our results indicate that both C/EBP proteins and CBP participate in the regulation of PEPCK gene transcription by thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997389     DOI: 10.1074/jbc.M201429200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

Review 2.  Hormonal regulation of gluconeogenic gene transcription in the liver.

Authors:  Nirmala Yabaluri; Murali D Bashyam
Journal:  J Biosci       Date:  2010-09       Impact factor: 1.826

3.  Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha.

Authors:  Min Jung Park; Hee Jeong Kong; Hye Young Kim; Hyeong Hoe Kim; Joon Hong Kim; Jae Hun Cheong
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

4.  Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone.

Authors:  Shalini Thakran; Pragya Sharma; Ramy R Attia; Roderick T Hori; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

5.  PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.

Authors:  Sara A Beddow; Arijeet K Gattu; Daniel F Vatner; Lauren Paolella; Abdulelah Alqarzaee; Nedda Tashkandi; Violeta B Popov; Christopher D Church; Matthew S Rodeheffer; Gary W Cline; John G Geisler; Sanjay Bhanot; Varman T Samuel
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

6.  Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 gene.

Authors:  Tao Li; Liqun Bai; Jing Li; Suzu Igarashi; Fayez K Ghishan
Journal:  Gastroenterology       Date:  2008-02-29       Impact factor: 22.682

7.  Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Authors:  Varman T Samuel; Sara A Beddow; Takanori Iwasaki; Xian-Man Zhang; Xin Chu; Christopher D Still; Glenn S Gerhard; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

8.  Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226.

Authors:  H-K Liu; S Perrier; C Lipina; D Finlay; H McLauchlan; C J Hastie; H S Hundal; C Sutherland
Journal:  BMC Mol Biol       Date:  2006-04-06       Impact factor: 2.946

9.  Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance.

Authors:  Naoki Kumashiro; Sara A Beddow; Daniel F Vatner; Sachin K Majumdar; Jennifer L Cantley; Fitsum Guebre-Egziabher; Ioana Fat; Blas Guigni; Michael J Jurczak; Andreas L Birkenfeld; Mario Kahn; Bryce K Perler; Michelle A Puchowicz; Vara Prasad Manchem; Sanjay Bhanot; Christopher D Still; Glenn S Gerhard; Kitt Falk Petersen; Gary W Cline; Gerald I Shulman; Varman T Samuel
Journal:  Diabetes       Date:  2013-02-19       Impact factor: 9.461

10.  Acetylation of C/EBPα inhibits its granulopoietic function.

Authors:  Deepak Bararia; Hui Si Kwok; Robert S Welner; Akihiko Numata; Menyhárt B Sárosi; Henry Yang; Sheena Wee; Sebastian Tschuri; Debleena Ray; Oliver Weigert; Elena Levantini; Alexander K Ebralidze; Jayantha Gunaratne; Daniel G Tenen
Journal:  Nat Commun       Date:  2016-03-23       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.